Showing results (41-50 of 402) with videos related to
Sort By:
Pageof 41
Clinical Kidney Journal|December 16, 2014
Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlationsSanjeev Sethi, Ladan Zand, Samih H Nasr, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 10, 2017
What are we missing in the clinical trials of focal segmental glomerulosclerosis?Ladan Zand, Richard J Glassock, An S De Vriese, et al.Journal of Nephrology|September 7, 2017
Treatment of primary membranous nephropathy: where are we now?Andrea Angioi, Nicola Lepori, Ana Coloma López, et al.Rheumatology (Oxford, England)|July 27, 2024
Granulomatosis with polyangiitis with and without antineutrophil cytoplasmic antibodies: a case-control studyMarta Casal Moura, Sam Falde, Sanjeev Sethi, et al.Kidney International Reports|January 11, 2020
An Open-Label Pilot Study of Adrenocorticotrophic Hormone in the Treatment of IgA Nephropathy at High Risk of ProgressionLadan Zand, Pietro Canetta, Richard Lafayette, et al.Journal of the American Society of Nephrology : JASN|November 1, 2016
A Proposal for a Serology-Based Approach to Membranous NephropathyAn S De Vriese, Richard J Glassock, Karl A Nath, et al.Journal of the American Society of Nephrology : JASN|March 9, 2021
Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin DepositsLadan Zand, S Vincent Rajkumar, Nelson Leung, et al.Kidney International|February 5, 2010
Recurrent membranoproliferative glomerulonephritis after kidney transplantationElizabeth C Lorenz, Sanjeev Sethi, Nelson Leung, et al.Mayo Clinic Proceedings|August 6, 2018
C3 Glomerulopathy: Ten Years' Experience at Mayo ClinicAishwarya Ravindran, Fernando C Fervenza, Richard J H Smith, et al.Nature Reviews. Nephrology|May 21, 2021
Therapeutic trials in adult FSGS: lessons learned and the road forwardAn S De Vriese, Jack F Wetzels, Richard J Glassock, et al.Pageof 41